دورية أكاديمية
GABRA1-Related Disorders: From Genetic to Functional Pathways.
| العنوان: | GABRA1-Related Disorders: From Genetic to Functional Pathways. |
|---|---|
| المؤلفون: | Musto E; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Dianalund, Denmark.; Pediatric Neurology, Department of Woman and Child Health and Public Health, Child Health Area, Catholic University UCSC, Rome, Italy.; Epilepsy and Movement Disorder Neurology, Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Italy., Liao VWY; Brain and Mind Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Johannesen KM; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Dianalund, Denmark.; Department of Genetics, University Hospital of Copenhagen, Copenhagen, Denmark., Fenger CD; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Dianalund, Denmark.; Amplexa Genetics, Odense, Denmark., Lederer D; Center for Human Genetics, Institut de Pathologie et de Génétique, Gosselies, Belgium., Kothur K; Kids Neuroscience Centre, Children's Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia., Fisk K; Sydney Genome Diagnostics, Western Sydney Genetics Program, Children's Hospital at Westmead, Sydney, New South Wales, Australia., Bennetts B; Sydney Genome Diagnostics, Western Sydney Genetics Program, Children's Hospital at Westmead, Sydney, New South Wales, Australia.; Specialty of Genomic Medicine, Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Vrielynck P; Reference Center for Refractory Epilepsy, Catholic University of Louvain, William Lennox Neurological Hospital, Ottignies, Belgium., Delaby D; Reference Center for Refractory Epilepsy, Catholic University of Louvain, William Lennox Neurological Hospital, Ottignies, Belgium., Ceulemans B; Department of Pediatric Neurology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium., Weckhuysen S; Applied & Translational Neurogenomics Group, VIB-Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium.; Department of Neurology, Antwerp University Hospital, Antwerp, Belgium.; Translational Neurosciences, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium., Sparber P; Research Center for Medical Genetics Moskvorechie 1, Moscow, Russia., Bouman A; Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Ardern-Holmes S; Kids Neuroscience Centre, Children's Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia.; T. Y. Nelson Department of Neurology and Neurosurgery, Children's Hospital at Westmead, Westmead, New South Wales, Australia., Troedson C; T. Y. Nelson Department of Neurology and Neurosurgery, Children's Hospital at Westmead, Westmead, New South Wales, Australia., Battaglia DI; Pediatric Neurology, Department of Woman and Child Health and Public Health, Child Health Area, Catholic University UCSC, Rome, Italy., Goel H; Hunter Genetics, Newcastle, New South Wales, Australia., Feyma T; Gillette Children's Specialty Healthcare, Saint Paul, MN, USA., Bakhtiari S; Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ, USA.; Departments of Child Health, Neurology, and Cellular & Molecular Medicine and Program in Genetics, University of Arizona College of Medicine, Phoenix, AZ, USA., Tjoa L; Townsville University Hospital, Douglas, Queensland, Australia., Boxill M; Department of Pediatrics, Viborg Regional Hospital, Viborg, Denmark., Demina N; Research Center for Medical Genetics Moskvorechie 1, Moscow, Russia., Shchagina O; Research Center for Medical Genetics Moskvorechie 1, Moscow, Russia., Dadali E; Research Center for Medical Genetics Moskvorechie 1, Moscow, Russia., Kruer M; Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ, USA.; Departments of Child Health, Neurology, and Cellular & Molecular Medicine and Program in Genetics, University of Arizona College of Medicine, Phoenix, AZ, USA., Cantalupo G; Child Neuropsychiatry Section, Department of Surgical Sciences, Dentistry, Gynecology and Paediatrics, University of Verona, Verona, Italy.; UOC Neuropsichiatria Infantile, Dipartimento Materno-Infantile, Azienda Ospedaliero-Universitaria Integrata (full member of the ERN EpiCare), Verona, Italy.; Center for Research on Epilepsies in Pediatric age (CREP), Verona, Italy., Contaldo I; Pediatric Neurology, Department of Woman and Child Health and Public Health, Child Health Area, Catholic University UCSC, Rome, Italy., Polster T; Department of Epileptology (Krankenhaus Mara), Bielefeld University Medical School, Bielefeld, Germany., Isidor B; CHU Nantes, Service de Génétique Médicale, Nantes, France., Bova SM; Pediatric Neurology Unit, V. Buzzi Children's Hospital, Milan, Italy., Fazeli W; Department of Neuropediatrics, Children's Hospital, University of Bonn, Bonn, Germany., Wouters L; Department of Pediatrics, Ziekenhuis Oost-Limburg, Genk, Belgium., Miranda MJ; Department of Pediatrics, Pediatric Neurology, Herlev University Hospital, Copenhagen University, Herlev, Denmark., Darra F; Child Neuropsychiatry Section, Department of Surgical Sciences, Dentistry, Gynecology and Paediatrics, University of Verona, Verona, Italy.; UOC Neuropsichiatria Infantile, Dipartimento Materno-Infantile, Azienda Ospedaliero-Universitaria Integrata (full member of the ERN EpiCare), Verona, Italy.; Center for Research on Epilepsies in Pediatric age (CREP), Verona, Italy., Pede E; Pediatric Neurology, Department of Woman and Child Health and Public Health, Child Health Area, Catholic University UCSC, Rome, Italy., Le Duc D; Department of Human Genetics, University of Leipzig Faculty of Medicine, Leipzig, Germany., Jamra RA; Department of Human Genetics, University of Leipzig Faculty of Medicine, Leipzig, Germany., Küry S; Service de Génétique Médicale, CHU Nantes, Nantes, France.; l'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France., Proietti J; Child Neuropsychiatry Section, Department of Surgical Sciences, Dentistry, Gynecology and Paediatrics, University of Verona, Verona, Italy.; Irish Centre for Fetal and Neonatal Translational Research, Child Neuropsychiatry, Cork, Ireland., McSweeney N; Department of Paediatrics, Cork University Hospital, Cork, Ireland., Brokamp E; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA., Andrews PI; Department of Neurology, Sydney Children's Hospital, Randwick, New South Wales, Australia., Gouray Garcia M; Centre Hospitalier de Cholet, Cholet, France., Chebib M; Brain and Mind Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Møller RS; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Dianalund, Denmark.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark., Ahring PK; Brain and Mind Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Gardella E; Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Dianalund, Denmark.; Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. |
| المصدر: | Annals of neurology [Ann Neurol] 2023 Aug 22. Date of Electronic Publication: 2023 Aug 22. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: New York, NY : Wiley-Liss Original Publication: Boston, Little, Brown. |
| مستخلص: | Objective: Variants in GABRA1 have been associated with a broad epilepsy spectrum, ranging from genetic generalized epilepsies to developmental and epileptic encephalopathies. However, our understanding of what determines the phenotype severity and best treatment options remains inadequate. We therefore aimed to analyze the electroclinical features and the functional effects of GABRA1 variants to establish genotype-phenotype correlations. Methods: Genetic and electroclinical data of 27 individuals (22 unrelated and 2 families) harboring 20 different GABRA1 variants were collected and accompanied by functional analysis of 19 variants. Results: Individuals in this cohort could be assigned into different clinical subgroups based on the functional effect of their variant and its structural position within the GABRA1 subunit. A homogenous phenotype with mild cognitive impairment and infantile onset epilepsy (focal seizures, fever sensitivity, and electroencephalographic posterior epileptiform discharges) was described for variants in the extracellular domain and the small transmembrane loops. These variants displayed loss-of-function (LoF) effects, and the patients generally had a favorable outcome. A more severe phenotype was associated with variants in the pore-forming transmembrane helices. These variants displayed either gain-of-function (GoF) or LoF effects. GoF variants were associated with severe early onset neurodevelopmental disorders, including early infantile developmental and epileptic encephalopathy. Interpretation: Our data expand the genetic and phenotypic spectrum of GABRA1 epilepsies and permit delineation of specific subphenotypes for LoF and GoF variants, through the heterogeneity of phenotypes and variants. Generally, variants in the transmembrane helices cause more severe phenotypes, in particular GoF variants. These findings establish the basis for a better understanding of the pathomechanism and a precision medicine approach in GABRA1-related disorders. Further studies in larger populations are needed to provide a conclusive genotype-phenotype correlation. ANN NEUROL 2023. (© 2023 American Neurological Association.) |
| References: | Masiulis S, Desai R, Uchański T, et al. GABAA receptor signalling mechanisms revealed by structural pharmacology. Nature 2019;565:454-459. Pettersen EF, Goddard TD, Huang CC, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci 2021;30:70-82. Chua HC, Chebib M. GABAA receptors and the diversity in their structure and pharmacology. Adv Pharmacol 2017;79:1-34. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(a) receptors. Nat Rev Neurosci 2005;6:215-229. Cossette P, Lortie A, Vanasse M, et al. Autosomal dominant juvenile myoclonic epilepsy and GABRA1. Adv Neurol 2005;95:255-263. Lachance-Touchette P, Brown P, Meloche C, et al. Novel α1 and γ2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy. Eur J Neurosci 2011;34:237-249. Maljevic S, Krampfl K, Cobilanschi J, et al. A mutation in the GABA(a) receptor alpha(1)-subunit is associated with absence epilepsy. Ann Neurol 2006;59:983-987. Johannesen K, Marini C, Pfeffer S, et al. Phenotypic spectrum of GABRA1: from generalized epilepsies to severe epileptic encephalopathies. Neurology 2016;87:1140-1151. Carvill GL, Weckhuysen S, McMahon JM, et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome. Neurology 2014;82:1245-1253. Gontika MP, Konialis C, Pangalos C, Papavasiliou A. Novel SCN1A and GABRA1 gene mutations with diverse phenotypic features and the question on the existence of a broader Spectrum of Dravet syndrome. Child Neurol Open 2017;4:2329048X17706794. Hernandez CC, Tian X, Hu N, et al. Dravet syndrome-associated mutations in GABRA1, GABRB2 and GABRG2 define the genetic landscape of defects of GABAA receptors. Brain Commun 2021;3:fcab033. Kodera H, Ohba C, Kato M, et al. De novo GABRA1 mutations in Ohtahara and west syndromes. Epilepsia 2016;57:566-573. Burgess R, Wang S, McTague A, et al. The genetic landscape of epilepsy of infancy with migrating focal seizures. Ann Neurol 2019;86:821-831. Zhang L, Liu X. Clinical phenotype and genotype of children with GABAA receptor α1 subunit gene-related epilepsy. Front Neurol 2022;13:941054. Maillard P-Y, Baer S, Schaefer É, et al. Molecular and clinical descriptions of patients with GABAA receptor gene variants (GABRA1, GABRB2, GABRB3, GABRG2): a cohort study, review of literature, and genotype-phenotype correlation. Epilepsia 2022;63:2519-2533. Hernandez CC, Macdonald RL. A structural look at GABAA receptor mutations linked to epilepsy syndromes. Brain Res 2019;1714:234-247. Qu S, Zhou C, Howe R, et al. The K328M substitution in the human GABAA receptor gamma2 subunit causes GEFS+ and premature sudden death in knock-in mice. Neurobiol Dis 2021;152:105296. Absalom NL, Liao VWY, Kothur K, et al. Gain-of-function GABRB3 variants identified in vigabatrin-hypersensitive epileptic encephalopathies. Brain Commun 2020;2:fcaa162)[cited 2021 Jan 4 ]. https://doi.org/10.1093/braincomms/fcaa162. Absalom NL, Liao VWY, Johannesen KMH, et al. Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies. Nat Commun 2022;13:1822. Ahring PK, Liao VWY, Lin S, et al. The de novo GABRA4 p.Thr300Ile variant found in a patient with early-onset intractable epilepsy and neurodevelopmental abnormalities displays gain-of-function traits. Epilepsia 2022;63:2439-2441. Ahring PK, Liao VWY, Gardella E, et al. Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy. Brain 2022;145:1299-1309. Chen W, Ge Y, Lu J, et al. Distinct functional alterations and therapeutic options of two pathological De novo variants of the T292 residue of GABRA1 identified in children with epileptic encephalopathy and neurodevelopmental disorders. Int J Mol Sci 2022;23:2723. Steudle F, Rehman S, Bampali K, et al. A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro. Sci Rep 2020;10:2379. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017;58:512-521. Liao VWY, Chua HC, Kowal NM, et al. Concatenated γ-aminobutyric acid type a receptors revisited: finding order in chaos. J Gen Physiol 2019;151:798-819. Liao VWY, Chebib M, Ahring PK. Efficient expression of concatenated α1β2δ and α1β3δ GABAA receptors, their pharmacology and stoichiometry. Br J Pharmacol 2021;178:1556-1573. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-424. Papandreou A, Danti FR, Spaull R, et al. The expanding spectrum of movement disorders in genetic epilepsies. Dev Med Child Neurol 2020;62:178-191. Brnich SE, Abou Tayoun AN, Couch FJ, et al. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med 2019;12:3. Popp B, Trollmann R, Büttner C, et al. Do the exome: a case of Williams-Beuren syndrome with severe epilepsy due to a truncating de novo variant in GABRA1. Eur J Med Genet 2016;59:549-553. Baker KE, Parker R. Nonsense-mediated mRNA decay: terminating erroneous gene expression. Curr Opin Cell Biol 2004;16:293-299. Bureau M, Dalla BB. Electroencephalographic characteristics of Dravet syndrome. Epilepsia 2011;52:13-23. Karkare KD, Menon RN, Radhakrishnan A, et al. Electroclinical characteristics and syndromic associations of “eye-condition” related visual sensitive epilepsies-a cross-sectional study. Seizure 2018;58:62-71. Johannesen KM, Iqbal S, Guazzi M, et al. Structural mapping of GABRB3 variants reveals genotype-phenotype correlations, 2021.[cited 2021 Dec 7 ]. Available from: https://www.medrxiv.org/content/10.1101/2021.06.04.21256727v1. Jiang X, Raju PK, D'Avanzo N, et al. Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome. Epilepsia 2019;60:1881-1894. Berecki G, Bryson A, Terhag J, et al. SCN1A gain of function in early infantile encephalopathy. Ann Neurol 2019;85:514-525. Pan Y, Cummins TR. Distinct functional alterations in SCN8A epilepsy mutant channels. J Physiol 2020;598:381-401. |
| معلومات مُعتمدة: | R01 NS106298 United States NS NINDS NIH HHS |
| تواريخ الأحداث: | Date Created: 20230822 Latest Revision: 20240106 |
| رمز التحديث: | 20240106 |
| DOI: | 10.1002/ana.26774 |
| PMID: | 37606373 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1531-8249 |
|---|---|
| DOI: | 10.1002/ana.26774 |